On August 9, local time, the official website of the White House issued a statement based on the monkeypox epidemic.

The U.S. Food and Drug Administration announced the approval of emergency use authorization for the intradermal injection of the monkeypox vaccine, a change that will increase the current vaccine supply fivefold, as only a smaller dose is required for intradermal injections, the statement noted.

  The statement noted that since the monkeypox outbreak, the U.S. Department of Health and Human Services has distributed more than 670,000 monkeypox vaccines to states and jurisdictions.

In the next phase, the government is preparing to distribute about 400,000 vaccine doses to states and jurisdictions. Under the new regulations, a new batch of vaccines will be available for about 2 million people.

  According to the statistics of the US Centers for Disease Control and Prevention, as of the 9th local time, the number of confirmed monkeypox cases in the United States was 9,493, and the number of confirmed cases in the world was 30,189.

(Headquarters reporter Zhao Miao)